Page 3 - Clinical Evolution News Today

ObvioHealth announces upgraded decentralized trial platform The company’s technology facilitates remote patient monitoring and integrates with a wide range of wearable sensors for checking patient vital signs. ObvioHealth has introduced a new platform that enables advanced remote-patient monitoring capabilities for decentralized trial solutions. The company’s decentralized platform and patient-centric smartphone app are designed to help create an ‘ecosystem’ ...

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions. OSP: Could you please share the ‘elevator presentation’ description of Vocalis—who you are, what you do, and what sets you apart?​ SH: Vocalis Health is an AI health tech company pioneering the development of vocal biomarkers – where health-related information is derived from analysis of people’s voice reco...

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer. Noxopharm has released the most recent survival data from its LuPIN prostate cancer study. The company reports results show a median overall survival (mOS) of 19.7 months, higher than all other mOS results for existing prostate cancer treatments in their own registration studies. These findings reportedly support evidence...

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants. Shimmer Research has announced its Verisense Pulse+ sensor for use with its Verisense wearable sensor platform. The device is designed to offer photoplethysmogram (PPG), galvanic skin response (GSR), and inertial measurement unit (IMU). According to the company, the PPG sensor monitors heart rate by using light abs...

A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients. Patient identification, recruitment and engagement are a struggle with any trial, no matter the condition at the center of the research. When the planned study involves a rare disease, the obstacles become even more formidable, thanks to a smaller population to find and draw from, patients scattered all over the cou...

Direct data capture a game changer for trials: Clinical Ink By Jenni Spinner An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience. Jonathan Andrus (JA), chief business officer with Clinical Ink, will be presenting eSource Direct Data Capture: Making Virtual Your Reality on Thursday, March 4 at 10:30 am EST. He shared a prev...

A leader from the global research services company shares how in-home services maximize patient convenience and COVID-19's impact on clinical studies.

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine. Tricia Barrett, senior vice president and managing director for Praxis, is one of the two presenters (the other Diane Montross, senior director of patient recruitment and retention at Moderna) for Operation Warp Speed: Recruitment and Retention, Launching a Recruitment Strategy for a Phase III COVID-19 Vaccine Trial, t...

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

AHA training aids researchers with heart-to-heart talks The American Heart Association’s Heart of Communicating Science modules are designed to help experts break complex talk into easy-to-understand language. Clinical researchers, medical professionals and other scientific minds often spend their days speaking with and listening to complex, elevated language. However, these professionals frequently need to discuss their work to public officials, patients, and othe...